230 likes | 244 Views
This meta-analysis synthesized data on the effects of CCR5-∆32, CCR2-64I, and SDF-1 3’A alleles on HIV-1 disease progression. It included both published and unpublished data to reduce publication bias and technical variability.
E N D
International Meta-Analysis of HIV Host Genetics Thomas R. O’Brien Division of Cancer Epidemiology and Genetics October 6, 2005
Meta Analysis of Individual Patient Data • Include all published and unpublished data • Comprehensive • Reduce publication bias • Standardized protocol • Reduce technical variability
Purpose • Synthesize all available data on the effects of CCR5-∆32, CCR2-64I and SDF-1 3’A alleles on HIV-1 disease progression
Genotypic Comparisons • European ancestry • CCR5 +/32 & CCR2 +/+ • CCR5 +/+ & CCR2 64I/+ or 64I/64I • CCR5 +/32 & CCR2 64I/+ or 64I/64I • CCR5 +/+ & CCR2 +/+ • African ancestry • CCR2 +/64I or CCR2 64I/64I • CCR2 +/+ • Both groups • SDF1 3’A/3’A • SDF1 3’A/+ or SDF1 +/+ • Allele Frequencies: • European ancestry • CCR5 32 ~10% • CCR2 64I ~10-15% • SDF1 3’A ~20% • African ancestry • CCR532 ~1.7% • CCR2 64I ~10-15% • SDF1 3’A ~6%
Meta-Analysis Database • Studies from United States, Europe and Australia • 1,746 seroconverters from 10cohorts • 581 AIDS cases • 972 with data on early HIV RNA level • 2,764 seroprevalent subjects from 12 cohorts
Standardization of Data • Seroconverters • Seroconversion defined as mid-point between the last HIV-1-negative and first HIV-1-positive visit • Both specimens obtained after enrollment in prospective cohort • Seroprevalent subjects • Time-scale originating at date of study entry • Follow-up censored as of January 1, 1996 • Communications between coordinating center and contributing investigators to verify that data adhered to common definitions of the meta-analysis
Standardization of Phenotypes • AIDS • 1987 CDC definition • Death • HIV-1 RNA level • Consistent lab method and specimen (serum or plasma) within each study • Measured 6 to 42 months after seroconversion
Standardization of Genotypes • Not attempted
Effects of CCR5-32, CCR2-64I and SDF-1 3’A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data JOHN P.A. IOANNIDIS, PHILIP S. ROSENBERG, JAMES J. GOEDERT, LESLEY J. ASHTON, SUSAN P. BUCHBINDER, ROEL A. COUTINHO, JESPER EUGEN-OLSEN, TERESA GALLART, TERESE L. KATZENSTEIN, LEONDIOS G. KOSTRIKIS, HARMJAN KUIPERS, LESLIE LOUIE, SIMON A. MALLAL, JOSEPH B. MARGOLICK, OLGA P. MARTINEZ, LAURENCE MEYER, NELSON L. MICHAEL, STEPHEN J. O’BRIEN, EVA OPERSKALSKI, GIUSSEPPE PANTALEO, G. PAOLO RIZZARDI, HANNEKE SCHUITEMAKER, HAYNES W. SHEPPARD, MICHAEL W. SMITH, GRAEME J. STEWART, IOANNIS D. THEODOROU, HENRIK ULLUM, ELISA VICENZI, DAVID VLAHOV, DAVID WILKINSON, CASSY-WORKMAN, JEAN-FRANCOIS ZAGURY, and THOMAS R. O'BRIEN for the INTERNATIONAL META-ANALYSIS of HIV HOST GENETICS Ann Intern Med, 2001
Summary • Both CCR5-32 and CCR2-64I • Confer ~25% reduction in the risk of AIDS • Associated with significantly lower HIV RNA • No consistent evidence of protection for SDF1-3’A/3’A
HIV-1 Meta-Analyses • Meta-analysis of individual participants' data in genetic epidemiology Am J Epidemiol, 2002 • Effects of CCR5-∆32 & CCR2-64I alleles on HIV-1 disease progression: The protection varies with duration of infection AIDS, 2003 • Effect of CCR5-Δ32 heterozygosity on the risk of perinatal HIV-1 infection: a meta-analysis JAIDS, 2003 • Effects of CCR5- Δ32 and CCR2 64I alleles on disease progression of perinatally HIV-infected children: an international meta-analysis AIDS, 2003
Relative Hazard for AIDS CCR2-64I in Seroconverters
Relative Hazard for AIDS SDF1 3’A/3’A (Log scale)
CCR5-D32 ALLELE Wild typeATACAGTCAGTATCAATTCTGGAAGAATTTCCAGACATTAAA ∆32ATACA--------------------------------TTAAA